Guest (sample extract access) Increased access optional Login
|
|
Hello. As a guest, you only have access to sample talk extracts from the
Neurodegenerative Diseases series. For increased access, you may
login or review methods of
obtaining more access.
Neurodegenerative Diseases:
Fundamentals, Research Methods, Latest Advances
For all those wishing to be briefed on the latest developments in the study and understanding of neurodegenerative diseases including: Molecular and Clinical Neurologists, Neuropsychiatrists, Geriatric Researchers and Clinical Geneticists, whether in Pharmaceutical Development, Biotechnology, Clinical Research or Academic Institutions.
Prof. John Hodges - MRC Cognition and Brain Sciences Unit, University of Cambridge, UK
John Hodges is Professor of Behavioural Neurology at the MRC Cognition and Brain Sciences Unit and the University Department of Neurology, Cambridge, UK. Professor Hodges has a particular interest in memory, language and early onset dementia syndromes. He directs the Memory and the Early Onset Dementia Clinics at Addenbrooke's Hospital and co-ordinates a multi-disciplinary research team consisting of neuropsychologists, behavioural neurologists and neuroimagers. He is very involved in carer support and founded the Frontotemporal Dementia Carer Support Group. Professor Hodges has extensive publications in the fields of neuropsychology and behavioural neurology. He has authored over 300 peer reviewed papers and approximately 100 chapters and reviews. He has written books on transient amnesia, and cognitive assessment for clinicians, and co-authored, with Dr. Berrios, a book on memory disorders and psychiatric practice. He recently edited the first textbook, dedicated to early onset dementia syndromes and is currently editing a book on frontotemporal dementia syndromes. He was the founding co-editor of Neurocase and is now associate editor of Brain.
Series Online Publication: Oct 2007
Pathology, Genetic and Molecular Aspects (1)
Pathology, Genetic and Molecular Aspects (2)
Novel Therapies in Neurodegeneration
|
|
|
